Artepharm Global Corp. (ARGC.OB) Announces $10 Million Investment for ArteQuick® Malaria Treatment
Artepharm Global Corporation announced today that it has signed an agreement with the Qater Foundation, The Chinese Federal Government and a private syndication for the purpose of attempting to eradicate malaria from East Africa’s Comoros Islands through Artepharm’s patented malaria treatment, ArteQuick. Malaria is prominent in the small island chain of Comoros, located in the Indian Ocean, with nearly 225,000 of the 800,000 residents of the islands being infected with the illness. Comoros is comprised of four main islands and several smaller islands. In 2007, Artepharm successfully reduced the malaria rate of one of the main islands, Moheli, from over…